In contrast, ATRX mutation (43.81%), which was considered as a molecular signature of low-grade glioma (LGG), was more likely to occur in the low SASP Score group than high SASP Score group (14.76%) (Fig. 2E). This evidence concerns the gene ATRX and low grade glioma.